𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo pharmacology of irindalone, a 5-HT2 receptor antagonist with predominant peripheral effects

✍ Scribed by Jørn Arnt; Klaus P. Bøgesø; Vita Boeck; Anne V. Christensen; Nils Dragsted; John Hyttel; Torben Skarsfeldt

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
756 KB
Volume
16
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurochemical profile in vitro of irinda
Neurochemical profile in vitro of irindalone: A5-HT2-receptor antagonist
✍ John Hyttel; Klaus BøGesø; Hanne LøVe LembøL; Jens-JøRgen Larsen; Eddi Meier 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

A new potential antihypertensive drug, irindalone (Lu 21 -098;( +)-(1 R,3S)-1-[2-[4-[3-(pf luoropheny1)-1 -indanyl]-1 -piperazinyl]ethyl]-2-imidazolidinone), has been characterized by a series of in vitro methods. lrindalone competitively inhibits peripheral and central serotonin;! (5-HT2) receptors

Regulation of striatal neuropeptide mRNA
Regulation of striatal neuropeptide mRNAs: Effects of the 5-HT2 antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesion
✍ C. Durand; A.M. Mathieu-Kia; M.-J. Besson; J. Penit-Soria 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

The intrastriatal injection of 6-hydroxydopamine (6-OHDA) in newborn rats produces a marked striatal dopamine (DA) depletion, accompanied by a serotonin (5-HT) hyperinnervation and an up-regulation of 5-HT receptors. The aim of the present study was to investigate whether the increase in 5-HT 2 rece